AWARDPURCHASE ORDEROther than small business
Purchase order 75N95023P00761CTR CONSULTING LLC
Overview
Award facts
- Net obligations
- $183.26K
- $183,257of $183.26K potential value
- Outlays (paid to date)
- $139.27K
- $139.27K paid of $183.26K obligated$139,268
- Period of performance
- Sep 11, 2023 to Sep 10, 2027
- Ends in 9 months
- Modifications
- 4
- Latest action Jul 31, 2026
- Contract type
- Purchase order
- PIID 75N95023P00761
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TECHNICAL CONSULTING SERVICES AND DATA ANALYSIS OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES. PERIOD OF PERFORMANCE: SEPTEMBER 11, 2023 - SEPTEMBER 10, 2024.
Dates and value
- Award date
- Signed on Sep 7, 2023
- Current value
- $183,257Base and exercised options
- Potential value (if all options are exercised)
- $183,257
Obligations by fiscal year of action
- FY2026: $43,989
- FY2025: $41,894
- FY2024: $49,874
- FY2023: $47,499
Total across 4 fiscal years: $183,257
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 31, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationLONDON, GBR
UEIS4VGJG8BDCD4
CAGE codeU1YF1
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeSole proprietorship
Parent companyCTR CONSULTING LLC
Business types and certifications
For-profit organizationLimited liability company
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded from
- National institute on drug abuse (0893)Program activities075-0893Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Wilmington, Delaware
Classification and competition
Classification
- Product or service (PSC)
- B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (service)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- 75N95023Q00552
- Solicitation date
- Aug 16, 2023
- Notices
- Combined Synopsis/Solicitation posted Aug 16, 2023
- Sources Sought posted Jul 27, 2023
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Technical consulting services and data analysis of glucagon-like PEPTIDE-1 (GLP-1) analogues.
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 7, 2023Base obligation at award: $47,499
- Latest action
- Jul 31, 2026 — Option exercisedModification P00004; obligation change +$43,989
- Latest substantive action
- Jul 31, 2026 — Option exercisedModification P00004; obligation change +$43,989
- Actions by type
- Base award1
- Option exercised2
- Change order1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $43,989
- Latest action: change in base and all options
- $43,989
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N950
- Treasury accounts
- 075-2023/2023-0893-000
- 075-2024/2024-0893-000
- 075-2025/2025-0893-000
- Object classes
- 25.2: Other services from non-Federal sources
- 25.6: Medical care
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression